✦ LIBER ✦

Pharmacological Profile of KP-496, a Novel Dual Antagonist for Cysteinyl Leukotriene Receptor (CysLT1R) and Thromboxane A2 Receptor (TP)

✍ Scribed by Ishimura, M.; Suda, M.; Kataoka, S.; Maeda, T.; Hiyama, Y.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of KP-496, a Novel Dual Antagoni

✍ Kurokawa, S.; Okuda, T.; Amakawa, M.; Suda, M.; Murata, T.; Hiyama, Y. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Effects of KP-496DPI, a Novel Dual Antag

✍ Suda, M.; Morizumi, K.; Ishimura, M.; Maeda, T.; Kataoka, S.; Hiyama, Y. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Effects of Inhaled KP-496, a Novel Dual

✍ SUDA, M; OKUDA, T; ISHIMURA, M; KUROKAWA, S; TOKUOKA, S; NAKAMURA, T; TAKAHASHI, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Effects of KP-496, a novel dual antagoni

✍ M Ishimura; M Suda; K Morizumi; S Kataoka; T Maeda; S Kurokawa; Y Hiyama 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 172 KB

Effects of KP-496, a novel dual antagoni

✍ N. Mizutani; M. Suda; M. Ishimura; S. Kurokawa; T. Nabe; S. Kohno 📂 Article 📅 2008 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 274 KB

Pharmacological profile of YM087, a nove

✍ Takeyuki Yatsu; Yuichi Tomura; Atsuo Tahara; Koh-ichi Wada; Junko Tsukada; Watar 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 258 KB